✦ LIBER ✦

426 PRETREATMENT SERUM IP-10 IS ASSOCIATED WITH THE FIRST PHASE DECLINE OF HCV-RNA AND OUTCOME OF THERAPY IN CHRONIC HEPATITIS C

✍ Scribed by M. Fukuda; H. Yatsuhashi; S. Hashimoto; S.K. Bae; Y. Motoyoshi; E. Ozawa; S. Nagaoka; S. Abiru; A. Komori; K. Migita; H. Fujioka; M. Nakamura; H. Ishibashi

Book ID: 117379571
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 43 KB
Volume: 54
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(11)60428-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Loss of serum HCV RNA at week 4 of inter

Loss of serum HCV RNA at week 4 of interferon-α therapy is associated with more favorable long-term response in patients with chronic hepatitis C

✍ Etsuro Orito; Masashi Mizokami; Kaoru Suzuki; Ken-Ichi Ohba; Tomoyoshi Ohno; Mas 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 554 KB

## Abstract To determine the virological factors associated with a favorable long‐term response to interferon‐α (IFN) therapy in chronic hepatitis C virus (HCV) infection, 61 Japanese patients with chronic HCV infection were treated with IFN for 24 weeks (780 million units in total) and followed fo

Combination of Il28 Rs12979860 Genotype

Combination of Il28 Rs12979860 Genotype With Pretreatment Serum IP-10 Levels is the Best Predictor of SVR to Peginterferon/Ribavirin Therapy in Chronic Hepatitis C; Gt1 Patients

✍ Rutter, Karoline ;Aberle, Judith H. ;Wrba, Fritz ;Beinhardt, Sandra ;Scherzer, T 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Systemic and intrahepatic interferon-gam

Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C

✍ Galia Askarieh; Åsa Alsiö; Paolo Pugnale; Francesco Negro; Carlo Ferrari; Avidan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 475 KB 👁 1 views

High systemic levels of interferon-gamma-inducible protein 10 kDa (IP-10) at onset of combination therapy for chronic hepatitis C virus (HCV) infection predict poor outcome, but details regarding the impact of IP-10 on the reduction of HCV RNA during therapy remain unclear. In the present study, we

1343 COMBINATION OF IL28 RS12979860 GENO

1343 COMBINATION OF IL28 RS12979860 GENOTYPE WITH PRETREATMENT SERUM IP-10 LEVELS IS THE BEST PREDICTOR OF SVR TO PEGINTERFERON/RIBAVIRIN THERAPY IN CHRONIC HEPATITIS C, GT1 PATIENTS

✍ Rutter, K.; Aberle, J.; Stättermayer, A.; Bernhardt, S.; Scherzer, T.M.; Holzman 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Serum chemokine levels are associated wi

Serum chemokine levels are associated with the outcome of pegylated interferon and ribavirin therapy in patients with chronic hepatitis C

✍ Suguru Yoneda; Takeji Umemura; Satoru Joshita; Tetsuya Ichijo; Akihiro Matsumoto 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB

Hepatic steatosis in chronic hepatitis C

Hepatic steatosis in chronic hepatitis C patients infected with genotype 2 is associated with insulin resistance, hepatic fibrosis and affects cumulative positivity of serum hepatitis C virus RNA in peginterferon and ribavirin combination therapy

✍ Yoshito Itoh; Takeshi Nishimura; Kanji Yamaguchi; Chihiro Yokomizo; Hideki Fujii 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 660 KB